If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksValereum Plc Regulatory News (VLRM.PL)

Share Price Information for Valereum Plc (VLRM.PL)

Share Price is delayed by 15 minutes
Get Live Data
2.49    -0.17 (-6.39%)
Bid:
2.48
Ask:
2.50
Spread: 0.02 (0.806%)
Market Cap: £13.51m
VLRM.PL Live PriceLast checked at - Aquis Stock Exchange

Intraday Valereum Plc Share Chart

Completion of £2 million Subscription

5 Jul 2024 07:00

RNS Number : 2479V
Valereum PLC
05 July 2024
 

 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR")

 

5/07/2024

Valereum Plc("Valereum" or the "Company")

Completion of £2 million Subscription

Exercise of Warrants and Options

Directors' Dealing

Valereum Plc (AQSE: VLRM) is pleased to announce it has concluded the raise of £2 million from its Chairman, James Formolli, through the issuance of 55,411,752 new ordinary shares of £0.001 each in the capital of the Company (the "Subscription Shares") at £0.036 per Subscription Share (the "Subscription Price") with no warrants attached (the "Subscription") and the issuance of 15,000,000 GATE Tokens - VLRM's utility token.

As announced previously, the proceeds of the raise will be used to fund Valereum's growth across its VLRM Markets, Technology and Capital verticals. In addition, the proceeds will be used to expand the utility of GATE Token across the VLRM ecosystem and to extinguish its remaining loan, following which, there will be no outstanding loan liabilities.

Exercise of Warrants and Options

The Company also announces that options and warrants have been exercised over a total of 6,757,692 ordinary shares of £0.001 each for total proceeds of £9,458, comprising 4,807,692 ordinary shares for James Formolli (Chairman), 825,000 ordinary shares for Peter Sekhon (Investor Relations Director), 825,000 ordinary shares for Karl Moss (CFO) and 300,000 ordinary shares for a service provider.

On completion of the Subscription and exercise of warrants, James Formolli's shareholding is expected to increase to 41.34%.

Rule 4.6 Statement - Related Party Transactions

In relation to James Formolli's subscription, the Directors (other than James Formolli) confirm that, having exercised reasonable care, skill and diligence, the related party transaction is fair and reasonable as far as the shareholders of the issuer are concerned.

Admission 

Application will be made for the listing of the new Ordinary Shares, which will rank pari passu with the existing Ordinary Shares in issue, to be admitted to trading on the AQSE Growth Market ("Admission"). Dealings are expected to commence on or about 10 July 2024 and the issue is subject only to Admission.

Total voting rights

Following the subscription and exercises of warrants and options, the Company's total number of Ordinary Shares in issue will be 171,332,349. This figure may be used by shareholders as the denominator for the calculation to determine if they are required to notify the Company of their interest in, or a change to their interest in, the Company's securities pursuant to the Company's Articles.

For further information, please contact as follows:

Enquiries:

Valereum Plc

James Formolli, Chairman

Tel: +971 4584 6284

 

Stanford Capital Partners

Tel: 023 3650 3650

Bob Pountney

Patrick Claridge

 

First Sentinel Corporate Finance

AQSE Corporate Adviser

Brian Stockbridge

Tel: +44 20 3855 5551

 

Further updates to follow in due course.

 

The Directors of the Company accept responsibility for the contents of this announcement.

 

For more information, please visit the Company's website at www.vlrm.com

 

NOTIFICATION OF TRANSACTIONS OF DIRECTORS, PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES OR CONNECTED PERSONS

 

 

 

1.

Details of the person discharging managerial responsibilities / person closely associated

 

a)

Name

James Formolli

 

2.

Reason for the Notification

 

a)

Position/status

Chairman

 

b)

Initial notification / Amendment

Initial notification

 

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

Name

Valereum Plc

 

b)

LEI

213800EJ8BFEQQ9POX79

 

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

Description of the Financial instrument, type of instrument

Ordinary shares of 0.1p each

 

Identification Code

GI000A2P2W41

 

b)

Nature of the transaction

Subscription of ordinary shares

 

c)

Price(s) and volume(s)

 

Price

Volume

£0.036 per Ordinary Share

55,411,752 Ordinary Shares

 

d)

Aggregated information:

· Aggregated volume

· Price

 

Single transaction, see details in item (c) above

 

e)

Date of the transaction

4 July 2024

 

f)

Place of the Transaction

Outside a trading venue

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Ordinary shares of 0.1p each

Identification Code

GI000A2P2W41

b)

Nature of the transaction

Exercise of warrants

c)

Price(s) and volume(s)

 

Price

Volume

£0.001

 per Ordinary Share

4,807,692 Ordinary Shares

d)

Aggregated information:

· Aggregated volume

· Price

 

Single transaction, see details in item (c) above

e)

Date of the transaction

4 July 2024

f)

Place of the Transaction

Outside a trading venue

 

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Peter Sekhon

2.

Reason for the Notification

a)

Position/status

Investor Relations Director 

b)

Initial notification / Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Valereum Plc

b)

LEI

213800EJ8BFEQQ9POX79

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Ordinary shares of 0.1p each

Identification Code

GI000A2P2W41

b)

Nature of the transaction

Exercise of warrants 

c)

Price(s) and volume(s)

 

Price

Volume

 £0.001

per Ordinary Share

 825,000 Ordinary Shares

d)

Aggregated information:

· Aggregated volume

· Price

 

Single transaction, see details in item (c) above

e)

Date of the transaction

4 July 2024

f)

Place of the Transaction

Outside a trading venue

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Karl Moss

2.

Reason for the Notification

a)

Position/status

Chief Financial Officer

b)

Initial notification / Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Valereum Plc

b)

LEI

213800EJ8BFEQQ9POX79

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Ordinary shares of 0.1p each

Identification Code

GI000A2P2W41

b)

Nature of the transaction

Exercise of warrants 

c)

Price(s) and volume(s)

 

Price

Volume

 £0.001

per Ordinary Share

 825,000 Ordinary Shares

d)

Aggregated information:

· Aggregated volume

· Price

 

Single transaction, see details in item (c) above

e)

Date of the transaction

4 July 2024

f)

Place of the Transaction

Outside a trading venue

 

TR-1: Standard form for notification of major holdings

 

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii:

Valereum Plc

1b. Please indicate if the issuer is a non-UK issuer  (please mark with an "X" if appropriate)

Non-UK issuer

X

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

X

An acquisition or disposal of financial instruments

An event changing the breakdown of voting rights

Other (please specify) iii:

3. Details of person subject to the notification obligation iv

Name

James Formolli

City and country of registered office (if applicable)

4. Full name of shareholder(s) (if different from 3.) v

Name

City and country of registered office (if applicable)

5. Date on which the threshold was crossed or reached vi:

04/07/2024

6. Date on which issuer notified (DD/MM/YYYY):

04/07/2024

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer (8.A + 8.B) vii

Resulting situation on the date on which threshold was crossed or reached

41.34%

41.34%

70,833,730

Position of previous notification (if

applicable)

9.72%

9.72%

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached viii

A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

Number of voting rights ix

% of voting rights

Direct

(DTR5.1)

Indirect

 (DTR5.2.1)

Direct

(DTR5.1)

Indirect

(DTR5.2.1)

Ordinary Shares GI000A2P2W41

70,833,730

41.34%

SUBTOTAL 8. A

70,833,730

41.34%

 

 

B 1: Financial Instruments according to DTR5.3.1R (1) (a)

Type of financial instrument

Expirationdate x

Exercise/Conversion Period xi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

SUBTOTAL 8. B 1

 

 

B 2: Financial Instruments with similar economic effect according to DTR5.3.1R (1) (b)

Type of financial instrument

Expirationdate x

Exercise/Conversion Period xi

Physical or cash

Settlement xii

Number of voting rights

% of voting rights

 

SUBTOTAL 8.B.2

 

 

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer xiii

X

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entity (please add additional rows as necessary) xiv

Name xv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

 

10. In case of proxy voting, please identify:

Name of the proxy holder

The number and % of voting rights held

The date until which the voting rights will be held

11. Additional information xvi

 

Place of completion

England, UK

Date of completion

04 July 2024

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NEXRIMTTMTBMTTI
Date   Source Headline
6th Jul 20267:00 amRNSQGP Progress Update
3rd Jul 20261:12 pmRNS-RValereum Vox Issue 6 Published
30th Jun 20266:15 pmRNSResults for the year ended 31 December 2025
19th Jun 20261:00 pmRNS-RValereum Vox Issue 5 Published
5th Jun 20264:32 pmRNS-RValereum Vox Issue 4 Published
1st Jun 20267:00 amRNSHolding(s) in Company
22nd May 20263:00 pmRNS-RValereum Vox Issue 3 Published
15th May 20267:00 amRNSPlacing and Subscription Raising £1,050,000
11th May 20264:10 pmRNS-RValereum Vox Issue 2 Published
23rd Apr 20261:45 pmRNS-RLaunch of new blog, Valereum Vox
22nd Apr 20267:00 amRNSDefinitive Agreement with QGP
21st Apr 20267:00 amRNSSettlement Agreement with Blubird
16th Apr 20267:00 amRNSDefinitive Agreement Update
10th Apr 20262:48 pmRNSReplacement - Coupon Payment Received
10th Apr 20262:07 pmRNSCoupon Payment Received
9th Apr 202611:32 amRNSShare Options and PDMR Dealings
31st Mar 20261:46 pmRNSInvestor Meeting
31st Mar 20267:31 amRNSProposed Strategic Integration and Coupon Payment
4th Mar 20267:00 amRNSOTCQB Approval
27th Feb 202610:53 amRNSVLRM Markets Organisational Update
25th Feb 20267:00 amRNSOption Agreement to Cancel 2 Million Warrants
16th Feb 20267:00 amRNSDirectorate Changes
16th Feb 20267:00 amRNSSigning of MoU with Integra Foundation
9th Feb 20267:00 amRNSSigning of MoU with RWA.io & Defactor
6th Feb 20267:00 amRNSChanges to Board of Directors
30th Jan 20262:00 pmRNSHolding(s) in Company
29th Jan 20267:00 amRNSSigning of MoU and Exercise of Warrants
27th Jan 20263:50 pmRNSHolding(s) in Company
26th Jan 20267:00 amRNSForward Strategy Update
21st Jan 20267:00 amRNSAgreement and Lifting of Suspension
22nd Dec 20257:00 amRNSContract
22nd Dec 20257:00 amRNSContract
17th Dec 20257:00 amRNSResignation of Corporate Adviser and Suspension
4th Dec 202510:56 amRNS-ROTC Application
2nd Dec 202510:34 amRNSUpdate on Capital Raise
25th Nov 20257:00 amRNSAgreement to Raise Capital
21st Nov 20257:00 amRNSExercise of Warrants
17th Nov 20257:00 amRNSCompletion of Subscription
14th Nov 20257:00 amRNSDeployment of DigiShares’ Tokenisation Platform
27th Oct 20257:00 amRNS-RCOINGT to List on VLRM Markets
10th Oct 20257:00 amRNSSubscription to Raise £600,000
7th Oct 20257:00 amRNSVLRM Markets’ Post Launch Update
1st Oct 20259:00 amRNSOption Agreement to Cancel 2m Warrants
25th Sep 20257:00 amRNSValereum Advances GATE Token Strategy
24th Sep 20254:47 pmRNSHolding(s) in Company
24th Sep 20257:00 amRNSInterim Results
19th Sep 20257:00 amRNS-RUpdate on Strategy Implementation
10th Sep 20257:00 amRNS-RVLRM to Co-host Exclusive Side Event at TOKEN2049
4th Sep 20257:00 amRNS-RCrypto and Multi Currency Payroll Solution
20th Aug 20251:00 pmRNS-RStrategic Collaboration with ZIGChain & DigiShares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.